Evaluating Nephrocheck ® as a Predictive Tool for Acute Kidney Injury

Acute kidney injury (AKI) is a common complication in critically ill patients in the intensive settings with increased risks of short- and long-term complications and mortality. AKI is also associated with an increased length of stay in intensive care units (ICU) and worse kidney function recovery a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:International journal of nephrology and renovascular disease Ročník 13; s. 85 - 96
Hlavní autoři: Nalesso, Federico, Cattarin, Leda, Gobbi, Laura, Fragasso, Antonio, Garzotto, Francesco, Calò, Lorenzo Arcangelo
Médium: Journal Article
Jazyk:angličtina
Vydáno: New Zealand Dove Medical Press Limited 01.01.2020
Dove
Dove Medical Press
Témata:
acute kidney injury (aki)
Biological markers
creatinine
critical care medicine
Health aspects
Hospital admission and discharge
Insulin
insulin-like growth factor binding protein 7 (igfbp-7)
intensive care unit
interleukin 18 (il-18)
Interleukins
kidney injury molecule 1 (kim-1)
liver-type fatty acid binding protein (l-fabp)
Medical research
Mortality
neutrophil gelatinase-associated lipocalin (ngal)
Protein binding
Review
Setting (Literature)
tissue inhibitor of metalloproteinase 2 (timp-2)
urine output
KIM-1
NGAL
IGFBP-7
interleukin-18
L-FABP
TIMP-2
ISSN:1178-7058, 1178-7058
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Acute kidney injury (AKI) is a common complication in critically ill patients in the intensive settings with increased risks of short- and long-term complications and mortality. AKI is also associated with an increased length of stay in intensive care units (ICU) and worse kidney function recovery at hospital discharge. The management of AKI is one of the major challenges for nephrologists and intensivists overall for its early diagnosis. The current KDIGO criteria used to define AKI include the serum creatinine and urinary output that are neither sensitive nor specific markers of kidney function, since they can be altered only after hours from the kidney injury. In order to allow an early AKI detection, in the last years, several studies focused on the identification of new biomarkers. Among all these markers, urinary insulin-like growth factor-binding protein (IGFBP-7) and tissue inhibitor of metalloproteinase (TIMP-2) have been proven as the best-performing and have been proposed as a predictive tool for the AKI detection in the critical settings in order to perform an early diagnosis. Patients undergoing major surgery, cardiac surgery, those with hemodynamic instability or those with sepsis are believed to be the top priority patient populations for the biomarker test. In this view, the urinary [TIMP-2] x [IGFBP-7] becomes an important tool for the early detection of patients at high risk for AKI and its integration with the local ICU experience has to provide a multidisciplinary management of AKI with the institution of a rapid response team in order to assess patients and customize AKI management.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1178-7058
1178-7058
DOI:10.2147/IJNRD.S198222